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Interference in peroxidase-linked assays by Parentrovite
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From the Department of Chemical Pathology, Westminster Hospital, Page Street, Landon SWI, UK Additional key phrases: drug interference; hyperglycaemia; hypolipaemia; ascorbic acid We report the consequences of interference by ascorbic acid (Vitamin C) injection (Parentrovite, Bencard, Brentford, UK) on peroxidase-linked coupled enzyme systems for substrate assay.
HISTORY
Mrs T was a 62-year-old lady who attended her GP complaining of abdominal pain. Blood samples taken by the GP were sent to the laboratory in Vacutainers (Becton-Dickinson, Oxford, UK) for analysis. Her haematology results were normal and her biochemistry results, analysed on an ERIS analyser (BDH, Poole, UK), were as follows:
In view of the raised glucose and the low cholesterol the GP was contacted, but was unable to reach the patient immediately. She promised to send a repeat specimen when the patient reattended her clinic. In the meantime the specimen was re-analysed on a BM Hitachi 717 (Boehringer Mannheim, Lewes, UK) analyser, which confirmed the high glucose and low cholesterol results. Nine days later a repeat specimen was received and was analysed on the BDH 'Eris' analyser. The biochemical results were similar to those previously obtained, but the glucose was now 19'7 mmollL. A triglyceride level measured on the same sample was, like the cholesterol, undetectable. All results were confirmed by analysis on the BM Hitachi 717.
DISCUSSION
Parentrovite IVHP consists of two ampoules which are given intravenously. Ampoule A contains 500 mg ascorbic acid, 160 mg nicotinamide and 1000 mg anhydrous glucose in 5 mL solution. Ampoule B contains 250 mg thiamine
The GP was informed of the results and stated that the only drugs being taken by the patient were erythromycin and diazepam. The sample was then sent to the District lipid laboratory where the cholesterol, triglyceride and glucose analyses were repeated on an American Monitor 'Parallel' analyser. The raised glucose and very low cholesterol and triglyceride results were confirmed.
In order to investigate the apparent hypolipidaemia lipid electrophoresis and plasma lipoproteins were measured. Both gave normal results. It was apparent therefore that something was affecting the lipid analyses' and probably increasing the glucose level. On considering the methods used for these analyses, it was observed that the lipid analyses involved a peroxidase reaction, while the glucose methods were based on glucose dehydrogenase methodology. The urate method used in the laboratory included a peroxidase/chromogen reaction and when urate was measured on the samples it was also undetectable.
The GP was contacted once again and carefully questioned about the collection procedures used. It became clear that because it was winter the patient was receiving prophylactic intravenous Parentrovite prior to collection of blood for the laboratory. This had happened each time that samples had been taken.
A further sample was taken, ensuring that this was not taken concurrently with a Parentrovite injection, and gave a glucose result of 5' 0 mmollL, triglyceride 2· 23 mmollL and cholesterol 7· 3 mmollL. This confirmed that Parentrovite administration was responsible for the analytical problems. hydrochloride, 4 mg riboflavine and 50 mg pyridoxine hydrochloride, also in 5 mL solution.
An experiment was carried out taking a pool of serum and adding increasing dilutions of either ampoule A or B. The samples were analysed for glucose, cholesterol, triglyceride and urate and the results obtained are shown in Table I .
It can be seen that the contents of Ampoule B had no effect on the analytical results. Ampoule A was shown to have a major lowering effect on all chemistries employing peroxidase/chromogen procedures, due to its high vitamin C content. It also caused an artefactual rise in the measured glucose level due to its high glucose content.
The major concern here is that if only a single analysis had been requested it is unlikely that the problem would have been recognized. This is especially so in the case of a single glucose measurement. Further unnecessary investigations could have been undertaken.
It has been demonstrated that ascorbic acid affects the peroxidase/chromogen reaction in several methods such as cholesterol, triglyceride, urate and some glucose methods. Ascorbic acid is a more powerful reducing agent than the chromogen used in these reactions and therefore inhibits colour production.
In this case it appears that the level of interference was such that the Parentrovite must have been given using the same syringe which was used to collect the blood samples, which were then transferred into vacutainer tubes. We were, however, unable to get the GP to confirm this. It was thought to be unethical to collect repeated samples from patients receiving Parentrovite therapy in order to follow the in vivo distribution of Parentrovite and its effects on peroxidaselinked assays.
CONCLUSION
Care must always be taken when interpreting unexpected analytical results. Repeating the tests on another analyser or another sample will not always resolve the problem even when the drugs received by the patient appear to have been documented. It is important to ask for details about all preparations being given since many doctors do not regard vitamin therapy as drug treatment.
